Literature DB >> 24919824

Quality of life and mild cognitive impairment in early Parkinson's disease: does subtype matter?

Rachael A Lawson1, Alison J Yarnall1, Gordon W Duncan1, Tien K Khoo2, David P Breen3, Roger A Barker3, Daniel Collerton1, John-Paul Taylor1, David J Burn1.   

Abstract

We evaluated the association between mild cognitive impairment (MCI) subtypes and quality of life (QoL) in 219 newly diagnosed Parkinson's disease (PD) patients without dementia. Participants completed neuropsychological tests of attention, executive function, visuospatial function, memory, and language, and reported QoL using the Parkinson's Disease Questionnaire. Impairments were most common in executive function, memory and attention. MCI subtypes were classified according to Movement Disorder Society Task Force criteria. More severe cognitive impairment was associated with poorer quality of life (p = 0.01), but subtype of impairment was not (p > 0.10), suggesting that the nature of cognitive impairment is less significant than its severity.

Entities:  

Keywords:  Parkinson's disease; mild cognitive impairment; quality of life; subtypes

Mesh:

Year:  2014        PMID: 24919824     DOI: 10.3233/JPD-140390

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  8 in total

1.  Cognition in non-demented Parkinson's disease vs essential tremor: A population-based study.

Authors:  Á Sánchez-Ferro; J Benito-León; E D Louis; I Contador; J Hernández-Gallego; V Puertas-Martín; F Bermejo-Pareja
Journal:  Acta Neurol Scand       Date:  2017-03-05       Impact factor: 3.209

2.  Impact of Mild Cognitive Impairment on Quality of Life in Young and Typical Onset Parkinson's Disease.

Authors:  Heather M Holden; Corrin N Schweer; Alexander I Tröster
Journal:  Mov Disord Clin Pract       Date:  2021-10-16

3.  Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson's disease.

Authors:  Milos Stanojlovic; Jean Pierre Pallais; Michael K Lee; Catherine M Kotz
Journal:  Mol Brain       Date:  2019-10-30       Impact factor: 4.041

4.  Neuropsychological Characteristics and Their Association with Higher-Level Functional Capacity in Parkinson's Disease.

Authors:  Kayoko Miura; Mie Matsui; Shutaro Takashima; Kortaro Tanaka
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-06-19

5.  Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.

Authors:  Elijah Mak; Li Su; Guy B Williams; Michael J Firbank; Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; Adrian M Owen; Tien K Khoo; David J Brooks; James B Rowe; Roger A Barker; David J Burn; John T O'Brien
Journal:  Brain       Date:  2015-07-14       Impact factor: 13.501

6.  Stability of mild cognitive impairment in newly diagnosed Parkinson's disease.

Authors:  Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; David P Breen; Tien K Khoo; Caroline H Williams-Gray; Roger A Barker; David J Burn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-03-01       Impact factor: 10.154

7.  Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson's disease model.

Authors:  Liyan Hou; Fuqiang Sun; Ruixue Huang; Wei Sun; Dan Zhang; Qingshan Wang
Journal:  Redox Biol       Date:  2019-02-08       Impact factor: 11.799

Review 8.  Visual dysfunction in Parkinson's disease.

Authors:  Rimona S Weil; Anette E Schrag; Jason D Warren; Sebastian J Crutch; Andrew J Lees; Huw R Morris
Journal:  Brain       Date:  2016-11-01       Impact factor: 15.255

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.